Related Articles

News
STAT+: Up and down the ladder: The latest comings and goings
June 3, 2022
San Francisco Biotechnology Network News
News
Comments Off on STAT+: Up and down the ladder: The latest comings and goings
From new hires to departures, promotions, and transfers, here are the latest comings and goings in the pharma industry. […]

News
STAT+: Four brain-computer interface companies you should watch (other than Neuralink)
July 25, 2022
San Francisco Biotechnology Network News
News
Comments Off on STAT+: Four brain-computer interface companies you should watch (other than Neuralink)
Elon Musk’s Neuralink has been the buzz of Silicon Valley and beyond. But it’s hardly the only company developing “brain-computer interfaces.” […]

News
STAT+: Alzheimer’s researchers try out an unfamiliar sensation: optimism
December 2, 2022
San Francisco Biotechnology Network News
News
Comments Off on STAT+: Alzheimer’s researchers try out an unfamiliar sensation: optimism
Scientific meetings about Alzheimer’s disease can be funereal affairs. But this year’s Clinical Trials in Alzheimer’s Disease meeting felt markedly different. […]